Clinical trial protocol for TARDOX: a phase I study to investigate the feasibility of targeted release of lyso-thermosensitive liposomal doxorubicin (ThermoDox®) using focused ultrasound in patients with liver tumours.
about
P311, Friend, or Foe of Tissue Fibrosis?Imaging Nanomedicine-Based Drug Delivery: a Review of Clinical StudiesLong-term radiological and histological outcomes following selective internal radiation therapy to liver metastases from breast cancerRecent advances in "smart" delivery systems for extended drug release in cancer therapy
P2860
Clinical trial protocol for TARDOX: a phase I study to investigate the feasibility of targeted release of lyso-thermosensitive liposomal doxorubicin (ThermoDox®) using focused ultrasound in patients with liver tumours.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Clinical trial protocol for TA ...... n patients with liver tumours.
@en
Clinical trial protocol for TA ...... ensitive liposomal doxorubicin
@nl
type
label
Clinical trial protocol for TA ...... n patients with liver tumours.
@en
Clinical trial protocol for TA ...... ensitive liposomal doxorubicin
@nl
prefLabel
Clinical trial protocol for TA ...... n patients with liver tumours.
@en
Clinical trial protocol for TA ...... ensitive liposomal doxorubicin
@nl
P2093
P2860
P50
P1476
Clinical trial protocol for TA ...... in patients with liver tumours
@en
P2093
Daniel Chung
Lucy F Griffiths
Mark R Middleton
Paul C Lyon
P2860
P2888
P356
10.1186/S40349-017-0104-0
P577
2017-11-02T00:00:00Z
P6179
1092383826